ID

39729

Description

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01685203

Link

https://clinicaltrials.gov/show/NCT01685203

Keywords

Versions (1)
  1. 2/13/20 2/13/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 13, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis C, Chronic NCT01685203

English

Eligibility Hepatitis C, Chronic NCT01685203

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
females must be practicing specific forms of birth control on study treatment, or be postmenopausal for more than 2 years or surgically sterile
Description

Gender Contraceptive methods | Postmenopausal state Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0449238
subjects must meet one of the following:
Description

Criteria Quantity Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
treatment-naive: subject has never received antiviral treatment for hepatitis c infection or
Description

Therapy naive | Antiviral Therapy Absent Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0280274
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0019196
treatment experienced (prior null responders, partial responders or relapsers to pegifn/rbv);
Description

Therapeutic procedure Experience | Non-responder PEGINTERFERON/RIBAVIRIN | Partial responder PEGINTERFERON/RIBAVIRIN | Relapse PEGINTERFERON/RIBAVIRIN

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0596545
UMLS CUI [2,1]
C0919875
UMLS CUI [2,2]
C1875630
UMLS CUI [3,1]
C4285679
UMLS CUI [3,2]
C1875630
UMLS CUI [4,1]
C0035020
UMLS CUI [4,2]
C1875630
body mass index (bmi) is ≥ 18 to < 38 kg/m^2.
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
chronic hcv genotype 1b infection/with or without cirrhosis or hcv genotype 4 infection/without cirrhosis for at least 6 months prior to study screening.
Description

Chronic Hepatitis C Genotype Duration | Liver Cirrhosis | Liver Cirrhosis Absent | Hepatitis C Genotype Duration | Liver Cirrhosis Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
UMLS CUI [1,3]
C0449238
UMLS CUI [2]
C0023890
UMLS CUI [3,1]
C0023890
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0019196
UMLS CUI [4,2]
C1533728
UMLS CUI [4,3]
C0449238
UMLS CUI [5,1]
C0023890
UMLS CUI [5,2]
C0332197
subject has plasma hcv rna level > 10,000 iu/ml at screening
Description

Hepatitis C virus RNA assay Plasma

Data type

boolean

Alias
UMLS CUI [1,1]
C1272251
UMLS CUI [1,2]
C0032105
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of severe, life-threatening or other significant sensitivity to any drug.
Description

Drug Allergy Severe Life Threatening | Drug Allergy Significant

Data type

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C2826244
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C0750502
females who were pregnant or planned to become pregnant, or breastfeeding, or gt4-infected males whose partners were pregnant or planning to become pregnant within 7 months (or per local rbv label) after their last dose of study drug/rbv.
Description

Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Hepatitis C Genotype | Gender Partner Pregnancy | Gender Partner Planned Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0019196
UMLS CUI [4,3]
C1533728
UMLS CUI [5,1]
C0079399
UMLS CUI [5,2]
C0682323
UMLS CUI [5,3]
C0032961
UMLS CUI [6,1]
C0079399
UMLS CUI [6,2]
C0682323
UMLS CUI [6,3]
C0032992
recent history of drug or alcohol abuse that could preclude adherence to the protocol.
Description

Substance Use Disorder Excludes Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
positive test result for hepatitis b surface antigen or anti-human immunodeficiency virus (hiv) antibodies.
Description

Hepatitis B surface antigen positive | HIV antibody positive

Data type

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0920548
Back to the top of the page

Similar models

Eligibility Hepatitis C, Chronic NCT01685203

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender Contraceptive methods | Postmenopausal state Duration
Item
females must be practicing specific forms of birth control on study treatment, or be postmenopausal for more than 2 years or surgically sterile
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
Criteria Quantity Fulfill
Item
subjects must meet one of the following:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Therapy naive | Antiviral Therapy Absent Hepatitis C
Item
treatment-naive: subject has never received antiviral treatment for hepatitis c infection or
boolean
C0919936 (UMLS CUI [1])
C0280274 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0019196 (UMLS CUI [2,3])
Therapeutic procedure Experience | Non-responder PEGINTERFERON/RIBAVIRIN | Partial responder PEGINTERFERON/RIBAVIRIN | Relapse PEGINTERFERON/RIBAVIRIN
Item
treatment experienced (prior null responders, partial responders or relapsers to pegifn/rbv);
boolean
C0087111 (UMLS CUI [1,1])
C0596545 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C1875630 (UMLS CUI [2,2])
C4285679 (UMLS CUI [3,1])
C1875630 (UMLS CUI [3,2])
C0035020 (UMLS CUI [4,1])
C1875630 (UMLS CUI [4,2])
Body mass index
Item
body mass index (bmi) is ≥ 18 to < 38 kg/m^2.
boolean
C1305855 (UMLS CUI [1])
Chronic Hepatitis C Genotype Duration | Liver Cirrhosis | Liver Cirrhosis Absent | Hepatitis C Genotype Duration | Liver Cirrhosis Absent
Item
chronic hcv genotype 1b infection/with or without cirrhosis or hcv genotype 4 infection/without cirrhosis for at least 6 months prior to study screening.
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0023890 (UMLS CUI [2])
C0023890 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0019196 (UMLS CUI [4,1])
C1533728 (UMLS CUI [4,2])
C0449238 (UMLS CUI [4,3])
C0023890 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Hepatitis C virus RNA assay Plasma
Item
subject has plasma hcv rna level > 10,000 iu/ml at screening
boolean
C1272251 (UMLS CUI [1,1])
C0032105 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Drug Allergy Severe Life Threatening | Drug Allergy Significant
Item
history of severe, life-threatening or other significant sensitivity to any drug.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2826244 (UMLS CUI [1,3])
C0013182 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Hepatitis C Genotype | Gender Partner Pregnancy | Gender Partner Planned Pregnancy
Item
females who were pregnant or planned to become pregnant, or breastfeeding, or gt4-infected males whose partners were pregnant or planning to become pregnant within 7 months (or per local rbv label) after their last dose of study drug/rbv.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0019196 (UMLS CUI [4,2])
C1533728 (UMLS CUI [4,3])
C0079399 (UMLS CUI [5,1])
C0682323 (UMLS CUI [5,2])
C0032961 (UMLS CUI [5,3])
C0079399 (UMLS CUI [6,1])
C0682323 (UMLS CUI [6,2])
C0032992 (UMLS CUI [6,3])
Substance Use Disorder Excludes Protocol Compliance
Item
recent history of drug or alcohol abuse that could preclude adherence to the protocol.
boolean
C0038586 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Hepatitis B surface antigen positive | HIV antibody positive
Item
positive test result for hepatitis b surface antigen or anti-human immunodeficiency virus (hiv) antibodies.
boolean
C0149709 (UMLS CUI [1])
C0920548 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial